Patent Number: 7,820,193

Title: Anti-angiogenic compositions and methods of use

Abstract: The present invention is directed to a stent comprising (a) a balloon expandable coronary stent; and (b) paclitaxel, in an amount that when tested in a chick chorioallantoic membrane assay is anti-angiogenic.

Inventors: Hunter; William L. (Vancouver, CA), Machan; Lindsay S. (Vancouver, CA), Arsenault; A. Larry (Paris, CA)

Assignee: Angiotech Pharmaceuticals, Inc.

International Classification: A61F 2/06 (20060101)

Expiration Date: 2018-10-26 0:00:00